1型糖尿病（T1D）の世界市場（～2026年）

• 英文タイトル：Global Type 1 Diabetes (T1D) Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY12795 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は1型糖尿病（T1D）のグローバル市場について調査・分析したレポートです。種類別（速効型インスリンアナログ、長時間作用型インスリンアナログ、プレミックスインスリンアナログ）市場規模、用途別（子供、大人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別1型糖尿病（T1D）の競争状況、市場シェア ・世界の1型糖尿病（T1D）市場：種類別市場規模 2015年-2020年（速効型インスリンアナログ、長時間作用型インスリンアナログ、プレミックスインスリンアナログ） ・世界の1型糖尿病（T1D）市場：種類別市場規模予測 2021年-2026年（速効型インスリンアナログ、長時間作用型インスリンアナログ、プレミックスインスリンアナログ） ・世界の1型糖尿病（T1D）市場：用途別市場規模 2015年-2020年（子供、大人） ・世界の1型糖尿病（T1D）市場：用途別市場規模予測 2021年-2026年（子供、大人） ・北米の1型糖尿病（T1D）市場分析：米国、カナダ ・ヨーロッパの1型糖尿病（T1D）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの1型糖尿病（T1D）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の1型糖尿病（T1D）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの1型糖尿病（T1D）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novo Nordisk、Sanofi、Eli Lilly、Merck、Boehringer Ingelheim、Samsung Bioepis、Biocon、Astellas、Janssen、Bristol-Myers Squibb、Lexicon、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.

Market Analysis and Insights: Global Type 1 Diabetes (T1D) Market
The global Type 1 Diabetes (T1D) market size is projected to reach US$ 1960 million by 2026, from US$ 1864 million in 2020, at a CAGR of 4.6%% during 2021-2026.

Global Type 1 Diabetes (T1D) Scope and Market Size
Type 1 Diabetes (T1D) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes (T1D) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Type 1 Diabetes (T1D) market is segmented into
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs

Segment by Application, the Type 1 Diabetes (T1D) market is segmented into
Children
Adults

Regional and Country-level Analysis
The Type 1 Diabetes (T1D) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Type 1 Diabetes (T1D) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Type 1 Diabetes (T1D) Market Share Analysis
Type 1 Diabetes (T1D) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Type 1 Diabetes (T1D) business, the date to enter into the Type 1 Diabetes (T1D) market, Type 1 Diabetes (T1D) product introduction, recent developments, etc.

The major vendors covered:
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi

レポート目次

---

1 Study Coverage
1.1 Type 1 Diabetes (T1D) Product Introduction
1.2 Market Segments
1.3 Key Type 1 Diabetes (T1D) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Type 1 Diabetes (T1D) Market Size Growth Rate by Type
1.4.2 Rapid Acting Insulin Analogs
1.4.3 Long Acting Insulin Analogs
1.4.4 Premix Insulin Analogs
1.5 Market by Application
1.5.1 Global Type 1 Diabetes (T1D) Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Type 1 Diabetes (T1D) Market Size, Estimates and Forecasts
2.1.1 Global Type 1 Diabetes (T1D) Revenue 2015-2026
2.1.2 Global Type 1 Diabetes (T1D) Sales 2015-2026
2.2 Global Type 1 Diabetes (T1D), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Type 1 Diabetes (T1D) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Type 1 Diabetes (T1D) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Type 1 Diabetes (T1D) Competitor Landscape by Players
3.1 Type 1 Diabetes (T1D) Sales by Manufacturers
3.1.1 Type 1 Diabetes (T1D) Sales by Manufacturers (2015-2020)
3.1.2 Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2015-2020)
3.2 Type 1 Diabetes (T1D) Revenue by Manufacturers
3.2.1 Type 1 Diabetes (T1D) Revenue by Manufacturers (2015-2020)
3.2.2 Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Type 1 Diabetes (T1D) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Type 1 Diabetes (T1D) Revenue in 2019
3.2.5 Global Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Type 1 Diabetes (T1D) Price by Manufacturers
3.4 Type 1 Diabetes (T1D) Manufacturing Base Distribution, Product Types
3.4.1 Type 1 Diabetes (T1D) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Type 1 Diabetes (T1D) Product Type
3.4.3 Date of International Manufacturers Enter into Type 1 Diabetes (T1D) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Type 1 Diabetes (T1D) Market Size by Type (2015-2020)
4.1.1 Global Type 1 Diabetes (T1D) Sales by Type (2015-2020)
4.1.2 Global Type 1 Diabetes (T1D) Revenue by Type (2015-2020)
4.1.3 Type 1 Diabetes (T1D) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Type 1 Diabetes (T1D) Market Size Forecast by Type (2021-2026)
4.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Type (2021-2026)
4.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Type (2021-2026)
4.2.3 Type 1 Diabetes (T1D) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Type 1 Diabetes (T1D) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Type 1 Diabetes (T1D) Market Size by Application (2015-2020)
5.1.1 Global Type 1 Diabetes (T1D) Sales by Application (2015-2020)
5.1.2 Global Type 1 Diabetes (T1D) Revenue by Application (2015-2020)
5.1.3 Type 1 Diabetes (T1D) Price by Application (2015-2020)
5.2 Type 1 Diabetes (T1D) Market Size Forecast by Application (2021-2026)
5.2.1 Global Type 1 Diabetes (T1D) Sales Forecast by Application (2021-2026)
5.2.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Application (2021-2026)
5.2.3 Global Type 1 Diabetes (T1D) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Type 1 Diabetes (T1D) by Country
6.1.1 North America Type 1 Diabetes (T1D) Sales by Country
6.1.2 North America Type 1 Diabetes (T1D) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Type 1 Diabetes (T1D) Market Facts & Figures by Type
6.3 North America Type 1 Diabetes (T1D) Market Facts & Figures by Application

7 Europe
7.1 Europe Type 1 Diabetes (T1D) by Country
7.1.1 Europe Type 1 Diabetes (T1D) Sales by Country
7.1.2 Europe Type 1 Diabetes (T1D) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Type 1 Diabetes (T1D) Market Facts & Figures by Type
7.3 Europe Type 1 Diabetes (T1D) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Type 1 Diabetes (T1D) by Region
8.1.1 Asia Pacific Type 1 Diabetes (T1D) Sales by Region
8.1.2 Asia Pacific Type 1 Diabetes (T1D) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Type 1 Diabetes (T1D) Market Facts & Figures by Type
8.3 Asia Pacific Type 1 Diabetes (T1D) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Type 1 Diabetes (T1D) by Country
9.1.1 Latin America Type 1 Diabetes (T1D) Sales by Country
9.1.2 Latin America Type 1 Diabetes (T1D) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Type 1 Diabetes (T1D) Market Facts & Figures by Type
9.3 Central & South America Type 1 Diabetes (T1D) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Type 1 Diabetes (T1D) by Country
10.1.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Country
10.1.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Type 1 Diabetes (T1D) Market Facts & Figures by Type
10.3 Middle East and Africa Type 1 Diabetes (T1D) Market Facts & Figures by Application

11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Type 1 Diabetes (T1D) Products Offered
11.1.5 Novo Nordisk Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Type 1 Diabetes (T1D) Products Offered
11.2.5 Sanofi Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Type 1 Diabetes (T1D) Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Type 1 Diabetes (T1D) Products Offered
11.4.5 Merck Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Samsung Bioepis
11.6.1 Samsung Bioepis Corporation Information
11.6.2 Samsung Bioepis Description and Business Overview
11.6.3 Samsung Bioepis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Products Offered
11.6.5 Samsung Bioepis Related Developments
11.7 Biocon
11.7.1 Biocon Corporation Information
11.7.2 Biocon Description and Business Overview
11.7.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biocon Type 1 Diabetes (T1D) Products Offered
11.7.5 Biocon Related Developments
11.8 Astellas
11.8.1 Astellas Corporation Information
11.8.2 Astellas Description and Business Overview
11.8.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Astellas Type 1 Diabetes (T1D) Products Offered
11.8.5 Astellas Related Developments
11.9 Janssen
11.9.1 Janssen Corporation Information
11.9.2 Janssen Description and Business Overview
11.9.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Janssen Type 1 Diabetes (T1D) Products Offered
11.9.5 Janssen Related Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Description and Business Overview
11.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Products Offered
11.10.5 Bristol-Myers Squibb Related Developments
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Type 1 Diabetes (T1D) Products Offered
11.1.5 Novo Nordisk Related Developments
11.12 Sanofi
11.12.1 Sanofi Corporation Information
11.12.2 Sanofi Description and Business Overview
11.12.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sanofi Products Offered
11.12.5 Sanofi Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Type 1 Diabetes (T1D) Market Estimates and Projections by Region
12.1.1 Global Type 1 Diabetes (T1D) Sales Forecast by Regions 2021-2026
12.1.2 Global Type 1 Diabetes (T1D) Revenue Forecast by Regions 2021-2026
12.2 North America Type 1 Diabetes (T1D) Market Size Forecast (2021-2026)
12.2.1 North America: Type 1 Diabetes (T1D) Sales Forecast (2021-2026)
12.2.2 North America: Type 1 Diabetes (T1D) Revenue Forecast (2021-2026)
12.2.3 North America: Type 1 Diabetes (T1D) Market Size Forecast by Country (2021-2026)
12.3 Europe Type 1 Diabetes (T1D) Market Size Forecast (2021-2026)
12.3.1 Europe: Type 1 Diabetes (T1D) Sales Forecast (2021-2026)
12.3.2 Europe: Type 1 Diabetes (T1D) Revenue Forecast (2021-2026)
12.3.3 Europe: Type 1 Diabetes (T1D) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Type 1 Diabetes (T1D) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Type 1 Diabetes (T1D) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Type 1 Diabetes (T1D) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Type 1 Diabetes (T1D) Market Size Forecast by Region (2021-2026)
12.5 Latin America Type 1 Diabetes (T1D) Market Size Forecast (2021-2026)
12.5.1 Latin America: Type 1 Diabetes (T1D) Sales Forecast (2021-2026)
12.5.2 Latin America: Type 1 Diabetes (T1D) Revenue Forecast (2021-2026)
12.5.3 Latin America: Type 1 Diabetes (T1D) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Type 1 Diabetes (T1D) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Type 1 Diabetes (T1D) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Type 1 Diabetes (T1D) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Type 1 Diabetes (T1D) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Type 1 Diabetes (T1D) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Type 1 Diabetes (T1D) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Type 1 Diabetes (T1D) Market Segments
Table 2. Ranking of Global Top Type 1 Diabetes (T1D) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Type 1 Diabetes (T1D) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Rapid Acting Insulin Analogs
Table 5. Major Manufacturers of Long Acting Insulin Analogs
Table 6. Major Manufacturers of Premix Insulin Analogs
Table 7. Global Type 1 Diabetes (T1D) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Type 1 Diabetes (T1D) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Type 1 Diabetes (T1D) Sales by Regions 2015-2020 (K MT)
Table 10. Global Type 1 Diabetes (T1D) Sales Market Share by Regions (2015-2020)
Table 11. Global Type 1 Diabetes (T1D) Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Type 1 Diabetes (T1D) Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Type 1 Diabetes (T1D) Sales Share by Manufacturers (2015-2020)
Table 14. Global Type 1 Diabetes (T1D) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Type 1 Diabetes (T1D) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes (T1D) as of 2019)
Table 16. Type 1 Diabetes (T1D) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Type 1 Diabetes (T1D) Price (2015-2020) (USD/MT)
Table 19. Type 1 Diabetes (T1D) Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Type 1 Diabetes (T1D) Product Type
Table 21. Date of International Manufacturers Enter into Type 1 Diabetes (T1D) Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Type 1 Diabetes (T1D) Sales by Type (2015-2020) (K MT)
Table 24. Global Type 1 Diabetes (T1D) Sales Share by Type (2015-2020)
Table 25. Global Type 1 Diabetes (T1D) Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Type 1 Diabetes (T1D) Revenue Share by Type (2015-2020)
Table 27. Type 1 Diabetes (T1D) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Type 1 Diabetes (T1D) Sales by Application (2015-2020) (K MT)
Table 29. Global Type 1 Diabetes (T1D) Sales Share by Application (2015-2020)
Table 30. North America Type 1 Diabetes (T1D) Sales by Country (2015-2020) (K MT)
Table 31. North America Type 1 Diabetes (T1D) Sales Market Share by Country (2015-2020)
Table 32. North America Type 1 Diabetes (T1D) Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Type 1 Diabetes (T1D) Revenue Market Share by Country (2015-2020)
Table 34. North America Type 1 Diabetes (T1D) Sales by Type (2015-2020) (K MT)
Table 35. North America Type 1 Diabetes (T1D) Sales Market Share by Type (2015-2020)
Table 36. North America Type 1 Diabetes (T1D) Sales by Application (2015-2020) (K MT)
Table 37. North America Type 1 Diabetes (T1D) Sales Market Share by Application (2015-2020)
Table 38. Europe Type 1 Diabetes (T1D) Sales by Country (2015-2020) (K MT)
Table 39. Europe Type 1 Diabetes (T1D) Sales Market Share by Country (2015-2020)
Table 40. Europe Type 1 Diabetes (T1D) Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Type 1 Diabetes (T1D) Revenue Market Share by Country (2015-2020)
Table 42. Europe Type 1 Diabetes (T1D) Sales by Type (2015-2020) (K MT)
Table 43. Europe Type 1 Diabetes (T1D) Sales Market Share by Type (2015-2020)
Table 44. Europe Type 1 Diabetes (T1D) Sales by Application (2015-2020) (K MT)
Table 45. Europe Type 1 Diabetes (T1D) Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Type 1 Diabetes (T1D) Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Type 1 Diabetes (T1D) Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Type 1 Diabetes (T1D) Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Type 1 Diabetes (T1D) Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Type 1 Diabetes (T1D) Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Application (2015-2020)
Table 54. Latin America Type 1 Diabetes (T1D) Sales by Country (2015-2020) (K MT)
Table 55. Latin America Type 1 Diabetes (T1D) Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Type 1 Diabetes (T1D) Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Type 1 Diabetes (T1D) Revenue Market Share by Country (2015-2020)
Table 58. Latin America Type 1 Diabetes (T1D) Sales by Type (2015-2020) (K MT)
Table 59. Latin America Type 1 Diabetes (T1D) Sales Market Share by Type (2015-2020)
Table 60. Latin America Type 1 Diabetes (T1D) Sales by Application (2015-2020) (K MT)
Table 61. Latin America Type 1 Diabetes (T1D) Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Type 1 Diabetes (T1D) Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Type 1 Diabetes (T1D) Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Type 1 Diabetes (T1D) Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Application (2015-2020)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Major Businesses
Table 72. Novo Nordisk Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Novo Nordisk Product
Table 74. Novo Nordisk Recent Development
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Major Businesses
Table 77. Sanofi Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Sanofi Product
Table 79. Sanofi Recent Development
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Major Businesses
Table 82. Eli Lilly Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Eli Lilly Product
Table 84. Eli Lilly Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Major Businesses
Table 87. Merck Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Major Businesses
Table 92. Boehringer Ingelheim Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Samsung Bioepis Corporation Information
Table 96. Samsung Bioepis Description and Major Businesses
Table 97. Samsung Bioepis Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Samsung Bioepis Product
Table 99. Samsung Bioepis Recent Development
Table 100. Biocon Corporation Information
Table 101. Biocon Description and Major Businesses
Table 102. Biocon Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Biocon Product
Table 104. Biocon Recent Development
Table 105. Astellas Corporation Information
Table 106. Astellas Description and Major Businesses
Table 107. Astellas Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Astellas Product
Table 109. Astellas Recent Development
Table 110. Janssen Corporation Information
Table 111. Janssen Description and Major Businesses
Table 112. Janssen Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Janssen Product
Table 114. Janssen Recent Development
Table 115. Bristol-Myers Squibb Corporation Information
Table 116. Bristol-Myers Squibb Description and Major Businesses
Table 117. Bristol-Myers Squibb Type 1 Diabetes (T1D) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Bristol-Myers Squibb Product
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Lexicon Corporation Information
Table 121. Lexicon Description and Major Businesses
Table 122. Lexicon Type 1 Diabetes (T1D) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Lexicon Product
Table 124. Lexicon Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Major Businesses
Table 127. Sanofi Type 1 Diabetes (T1D) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Sanofi Product
Table 129. Sanofi Recent Development
Table 130. Global Type 1 Diabetes (T1D) Sales Forecast by Regions (2021-2026) (K MT)
Table 131. Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Type 1 Diabetes (T1D) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Type 1 Diabetes (T1D) Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Type 1 Diabetes (T1D) Sales Forecast by Country (2021-2026) (K MT)
Table 135. North America: Type 1 Diabetes (T1D) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Type 1 Diabetes (T1D) Sales Forecast by Country (2021-2026) (K MT)
Table 137. Europe: Type 1 Diabetes (T1D) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Type 1 Diabetes (T1D) Sales Forecast by Region (2021-2026) (K MT)
Table 139. Asia Pacific: Type 1 Diabetes (T1D) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Type 1 Diabetes (T1D) Sales Forecast by Country (2021-2026) (K MT)
Table 141. Latin America: Type 1 Diabetes (T1D) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Type 1 Diabetes (T1D) Sales Forecast by Country (2021-2026) (K MT)
Table 143. Middle East and Africa: Type 1 Diabetes (T1D) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Type 1 Diabetes (T1D) Players
Table 148. Type 1 Diabetes (T1D) Customers List
Table 149. Type 1 Diabetes (T1D) Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Type 1 Diabetes (T1D) Product Picture
Figure 2. Global Type 1 Diabetes (T1D) Sales Market Share by Type in 2020 & 2026
Figure 3. Rapid Acting Insulin Analogs Product Picture
Figure 4. Long Acting Insulin Analogs Product Picture
Figure 5. Premix Insulin Analogs Product Picture
Figure 6. Global Type 1 Diabetes (T1D) Sales Market Share by Application in 2020 & 2026
Figure 7. Children
Figure 8. Adults
Figure 9. Type 1 Diabetes (T1D) Report Years Considered
Figure 10. Global Type 1 Diabetes (T1D) Market Size 2015-2026 (US$ Million)
Figure 11. Global Type 1 Diabetes (T1D) Sales 2015-2026 (K MT)
Figure 12. Global Type 1 Diabetes (T1D) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2015-2020)
Figure 14. Global Type 1 Diabetes (T1D) Sales Market Share by Region in 2019
Figure 15. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2015-2020)
Figure 16. Global Type 1 Diabetes (T1D) Revenue Market Share by Region in 2019
Figure 17. Global Type 1 Diabetes (T1D) Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Type 1 Diabetes (T1D) Revenue in 2019
Figure 19. Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2015-2020)
Figure 21. Global Type 1 Diabetes (T1D) Sales Market Share by Type in 2019
Figure 22. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2015-2020)
Figure 23. Global Type 1 Diabetes (T1D) Revenue Market Share by Type in 2019
Figure 24. Global Type 1 Diabetes (T1D) Market Share by Price Range (2015-2020)
Figure 25. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2015-2020)
Figure 26. Global Type 1 Diabetes (T1D) Sales Market Share by Application in 2019
Figure 27. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2015-2020)
Figure 28. Global Type 1 Diabetes (T1D) Revenue Market Share by Application in 2019
Figure 29. North America Type 1 Diabetes (T1D) Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Type 1 Diabetes (T1D) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Type 1 Diabetes (T1D) Sales Market Share by Country in 2019
Figure 32. North America Type 1 Diabetes (T1D) Revenue Market Share by Country in 2019
Figure 33. U.S. Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Type 1 Diabetes (T1D) Market Share by Type in 2019
Figure 38. North America Type 1 Diabetes (T1D) Market Share by Application in 2019
Figure 39. Europe Type 1 Diabetes (T1D) Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Type 1 Diabetes (T1D) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Type 1 Diabetes (T1D) Sales Market Share by Country in 2019
Figure 42. Europe Type 1 Diabetes (T1D) Revenue Market Share by Country in 2019
Figure 43. Germany Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Type 1 Diabetes (T1D) Market Share by Type in 2019
Figure 54. Europe Type 1 Diabetes (T1D) Market Share by Application in 2019
Figure 55. Asia Pacific Type 1 Diabetes (T1D) Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Type 1 Diabetes (T1D) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Region in 2019
Figure 58. Asia Pacific Type 1 Diabetes (T1D) Revenue Market Share by Region in 2019
Figure 59. China Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Type 1 Diabetes (T1D) Market Share by Type in 2019
Figure 82. Asia Pacific Type 1 Diabetes (T1D) Market Share by Application in 2019
Figure 83. Latin America Type 1 Diabetes (T1D) Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Type 1 Diabetes (T1D) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Type 1 Diabetes (T1D) Sales Market Share by Country in 2019
Figure 86. Latin America Type 1 Diabetes (T1D) Revenue Market Share by Country in 2019
Figure 87. Mexico Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Type 1 Diabetes (T1D) Market Share by Type in 2019
Figure 94. Latin America Type 1 Diabetes (T1D) Market Share by Application in 2019
Figure 95. Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Type 1 Diabetes (T1D) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Type 1 Diabetes (T1D) Revenue Market Share by Country in 2019
Figure 99. Turkey Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Type 1 Diabetes (T1D) Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Type 1 Diabetes (T1D) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Type 1 Diabetes (T1D) Market Share by Type in 2019
Figure 106. Middle East and Africa Type 1 Diabetes (T1D) Market Share by Application in 2019
Figure 107. North America Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Type 1 Diabetes (T1D) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

---